1. Canadian Product Monograph for carfilzomib (Kyprolis) updated

   News item 11 April 2020 Pages: 1 - 1

2. EMA study shows no change needed in use of three DOACs

   News item 11 April 2020 Pages: 2 - 2

3. Fatal respiratory depression with benzodiazepines and opioids

   News item 11 April 2020 Pages: 3 - 3

4. FDA requests market withdrawal of all ranitidine products

   News item 11 April 2020 Pages: 4 - 4

5. EMA: continue use of ACE inhibitors, sartans during COVID-19 pandemic

   News item 11 April 2020 Pages: 5 - 5

6. Adverse drug reaction rate in Saudi Arabia exceeds 25%

   Clinical study 11 April 2020 Pages: 6 - 6

7. Effect of vaccination granulomas in children with aluminium allergy

   Clinical study 11 April 2020 Pages: 7 - 7

8. Imatninib versus dasatinib, nilotinib: lower risk of ED visits and costs

   Clinical study 11 April 2020 Pages: 8 - 8

9. Influenza vaccination by obstetricians: effect of media reports

   Clinical study 11 April 2020 Pages: 9 - 9

10. Pilot pharmacovigilance initiative in Malawi

    Clinical study 11 April 2020 Pages: 10 - 10

11. PPI use increases risk of fracture in paediatric patients

    Clinical study 11 April 2020 Pages: 11 - 11

12. Risk of mortality reduced during opioid agonist treatment

    Clinical study 11 April 2020 Pages: 12 - 12

13. Standardized Antimicrobial Administration Ratio assesses overuse

    Clinical study 11 April 2020 Pages: 13 - 13

14. Other adverse reaction research

    News item 11 April 2020 Pages: 14 - 14

15. Agaricus blazei Murill extract/antineoplastics

    Case report 11 April 2020 Pages: 15 - 15

16. Saccharomyces-boulardii

    Case report 11 April 2020 Pages: 16 - 16

17. Aciclovir/carboplatin/cisplatin/ganciclovir

    Case report 11 April 2020 Pages: 17 - 17

18. Aciclovir/phenytoin/prednisone

    Case report 11 April 2020 Pages: 18 - 18

19. Adalimumab

    Case report 11 April 2020 Pages: 19 - 19

20. Adalimumab

    Case report 11 April 2020 Pages: 20 - 20

21. Adalimumab/methotrexate

    Case report 11 April 2020 Pages: 21 - 21

22. Adalimumab/prednisone

    Case report 11 April 2020 Pages: 22 - 22

23. Adalimumab/vancomycin

    Case report 11 April 2020 Pages: 23 - 23

24. Adenosine

    Case report 11 April 2020 Pages: 24 - 24

25. Adenosine/diltiazem/metoprolol

    Case report 11 April 2020 Pages: 25 - 25

26. Afatinib

    Case report 11 April 2020 Pages: 26 - 26

27. Aflibercept

    Case report 11 April 2020 Pages: 27 - 27

28. Alendronic acid

    Case report 11 April 2020 Pages: 28 - 28

29. Alirocumab

    Case report 11 April 2020 Pages: 29 - 29

30. Alirocumab

    Case report 11 April 2020 Pages: 30 - 30

31. Allopurinol

    Case report 11 April 2020 Pages: 31 - 31

32. Alprostadil/oxytocin

    Case report 11 April 2020 Pages: 32 - 32

33. Alteplase

    Case report 11 April 2020 Pages: 33 - 33

34. Alteplase/bivalirudin/heparin

    Case report 11 April 2020 Pages: 34 - 34

35. Amfetamine abuse

    Case report 11 April 2020 Pages: 35 - 35

36. Aminolevulinic-acid/bupivacaine

    Case report 11 April 2020 Pages: 36 - 36

37. Amiodarone

    Case report 11 April 2020 Pages: 37 - 37

38. Amiodarone

    Case report 11 April 2020 Pages: 38 - 38

39. Amiodarone

    Case report 11 April 2020 Pages: 39 - 39

40. Amiodarone

    Case report 11 April 2020 Pages: 40 - 40

41. Amiodarone

    Case report 11 April 2020 Pages: 41 - 41

42. Amiodarone

    Case report 11 April 2020 Pages: 42 - 42

43. Amiodarone

    Case report 11 April 2020 Pages: 43 - 43

44. Amiodarone/arsenic/sotalol

    Case report 11 April 2020 Pages: 44 - 44

45. Amiodarone/chlortalidone

    Case report 11 April 2020 Pages: 45 - 45

46. Amiodarone/lidocaine

    Case report 11 April 2020 Pages: 46 - 46

47. Amiodarone/lidocaine

    Case report 11 April 2020 Pages: 47 - 47

48. Amisulpride/physostigmine

    Case report 11 April 2020 Pages: 48 - 48

49. Amlodipine/β-adrenergic receptor antagonists/dronedarone

    Case report 11 April 2020 Pages: 49 - 49

50. Amlodipine/levothyroxine-sodium

    Case report 11 April 2020 Pages: 50 - 50